Site Closedown Checklist for UoL Sponsored CTIMP Studies

Similar documents
Standard Operating Procedure (SOP) Research and Development Office

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

SOP MONITORING & OVERSIGHT OF RESEARCH ACTIVITY. Contact Jess Bisset, Research Operations Manager x20227

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

Trial Management: Trial Master Files and Investigator Site Files

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

Joint R&D Support Office SOP S-2011 UHL

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

Document Title: Investigator Site File. Document Number: 019

SOP-QA-28 V2. Approver: Prof Maggie Cruickshank, R&D Director Approver: Prof Steve Heys, Head of School

Study Monitoring Plan Template

Standard Operating Procedure (SOP) Research and Development Office

STANDARD OPERATING PROCEDURE

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Details: Approval: Distribution & Storage: Pharmacovigilance for Researchers for UoL / LTHT Sponsored CTIMPs. Standard Operating Procedure

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Setting up a Clinical Trial

Investigator Site File Standard Operating Procedure (SOP)

Unofficial copy not valid

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

Standard Operating Procedure

managing or activities.

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

STANDARD OPERATING PROCEDURE SOP 325

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

Keele Clinical Trials Unit

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Standard Operating Procedures

STH Researcher. Recording of research information in patient case notes

Safety Reporting in Clinical Research Policy Final Version 4.0

Good Clinical Practice: A Ground Level View

Standard Operating Procedure (SOP)

Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019

Storage and Archiving of Research Documents SOP 6

Clinical Trial Readiness Checklist October 2014

Governance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

Monitoring Clinical Trials

Keele Clinical Trials Unit

VCU Clinical Research Quality Assurance Assessment

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

Once the feasibility assessment has been conducted the study team will be notified via (Appendix 3) of the outcome and whether the study is;

Research & Development Quality Manual

STANDARD OPERATING PROCEDURE

COMPETENCY FRAMEWORK

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

STANDARD OPERATING PROCEDURE SOP 205

Clinical Trial Quality Assurance Common Findings

Standard Operating Procedure Research Governance

MANAGEMENT OF PROTOCOL AND GCP DEVIATIONS AND VIOLATIONS

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

Standard Operating Procedure (SOP) Research and Development Office

QUALITY ASSURANCE PROGRAM

STANDARD OPERATING PROCEDURE

SOP WP6-QUAL-04, Version 1.0, 23 February 2014 Page 1 of 8. SOP Title: Laboratory (GCLP) supervision visits

Risk Assessment. Version Number 1.0 Effective Date: 21 st March Sponsored Research

Research Staff Training

Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

GCP INSPECTION CHECKLIST

Document Number: 006. Version: 1. Date ratified: Name of originator/author: Heidi Saunders, Senior Portfolio Coordinator

Document Title: Study Data SOP (CRFs and Source Data)

M. Rickard, Research Governance and GCP Manager R. Fay Research Governance and GCP Manager Elizabeth Clough, Governance Operations Manager

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

Standard Operating Procedures

NN SS 401 NEURONEXT NETWORK STANDARD OPERATING PROCEDURE FOR SITE SELECTION AND QUALIFICATION

PLATELET-ORIENTED INHIBITION ISCHEMIC STROKE (POINT) MONITORING PLAN IN NEW TIA AND MINOR. Version 2.0 Updated 11 May 2017

1. INTRODUCTION 2. SCOPE 3. PROCESS

STANDARD OPERATING PROCEDURE

The GCP Perspective on Study Monitoring

STANDARD OPERATING PROCEDURE

SOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Research & Development. Case Report Form SOP. J H Pacynko and J Illingworth. Research, pharmacy and R&D staff

Good Documentation Practices. Human Subject Research. for

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies

Document Title: Informed Consent for Research Studies

Risk Assessment and Monitoring

Auditing of Clinical Trials

Cancer Research UK Clinical Trials/Research Unit Glasgow. Quality System

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

Research Adverse Event and Safety Reporting Procedures Outcome Statement: Title:

Quality Assurance in Clinical Research at RM/ICR. GCP Compliance Team, Clinical R&D

Reference Number: UHB 253 Version Number: 1 Date of Next Review: 22/01/2018 Previous Trust/LHB Reference Number: SR-RG-015

Standard Operating Procedure:

SOP18b: Standard Operating Procedure for Preparing for External Audit and Inspection

ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM

Self-Monitoring Tool

Preparation for an MHRA GCP Inspection including Training on New and Up-dated SOPs

IDENTIFYING, RECORDING AND REPORTING ADVERSE EVENTS FOR CLINICAL INVESTIGATIONS OF MEDICAL DEVICES

Transcription:

Site Closedown Checklist for UoL Sponsored CTIMP Studies Site Information Site: Study Title: UoL study number: Centre name: Investigator: Date of Visit: Date of Report Date Responses due by: List of site and monitoring personnel in attendance Name Position Study Status Planned patient number Number of patients randomised Number of patients completed Number of patients withdrawn Number of patients lost to follow up Comments: 1. Protocol Is the current approved protocol on file? Is the protocol signed and dated? Are superseded protocols on file? Is there a protocol deviation log on file? Have protocol deviations been reported/reviewed by PI? 1

2. Ethics/HRA Are all original applications/submissions/approvals on file? Are all substantial amendments complete and on file? Are all non substantial amendments complete and on file? Correspondence on file? Notification of trial completion on file? 3. Competent Authority Are all original applications/submissions/approvals on file? Is there CTA acknowledgement of amendment letter/s? Notification of trial completion on file? MHRA Correspondence on file? 4. R&I/ R&D Are all original applications/submissions/approvals on file? Are all substantial amendment/s complete and on file? Are all non substantial amendment/s complete and on file? Notification of trial completion on file? R&I/R&D Correspondence on file? 2

5. Investigator Site Personnel Is the delegation of authority and signature log updated to reflect end of study? Confirm that all CVs/GCP/training records are up to date and on file 6. Standard Operating Procedures Are the most current SOPs on file? Standard Operating Procedures Read List completed for all study team members? 7. Study Documentation Is the current approved patient documentation on file? Are all superseded patient documents on file? Are previous versions of study documentation marked as Superseded? Is there a copy of the current Case Report Form on file? Are all superseded Case Report Forms on file? 8. Subject Documentation Is there a current screening log template on file? Is the Subject Screening log complete? Is there a current Enrolment Log template on file? 3

Is the Enrolment Log complete, including an outcome for each subject? 9. Randomisation Is there documentation of the Randomisation Process on file? Where is the Master Randomisation List held? Evidence of correct blinding as per study protocol? 10. Informed Consent Are all consent forms present and correctly completed? Has 100% consent audit been undertaken and documentation of the audit on file? Is informed consent process properly documented in the medical/trial records? 11. Safety Reporting/Pharmacovigilance Items discussed/verified Yes No N/A Comments Are SAE reporting Guidelines/SOP and Pharmacovigilance/Governance contact on file? Is there a Current SAE form Template on file? Are SAE reports and associated acknowledgement correspondence from Sponsor/R&D on file? Have all SAEs been reviewed against the current Reference Safety Information? Are SUSAR reporting guidelines on file? Are SUSAR reports and associated acknowledgement correspondence from Sponsor/ MHRA/R&D on file? 4

Are there signed and dated annual Development Safety Update Report(s) on file? 12. Reference Safety Information Items discussed/verified Yes No N/A Comments Have there been any changes to the Reference Safety Information? If changes have been made to the reference safety information has a substantial amendment been submitted to the MHRA? Is there a current signed and dated Investigator Brochure (IB) on file? Are superseded IB brochures on file? Is there a current signed and dated Summary of Product Characteristics (SmPC) on file? Are Superseded SmPCs on file? Are there any Safety alert updates on file? 13. Monitoring Items discussed/verified Yes No N/A Comments Is study initiation and subsequent monitoring visit documentation on file? Is the study specific monitoring plan on file (UHL CTIMP studies only)? Is the monitoring log complete and on file? 14. Clinical Laboratory/Specimen Collections Have central Labs been used? Are the current and previous Central Lab accreditations on file? Are Central Lab normal reference ranges on file? Have Local Labs been used? Are the Local Laboratory current and previous accreditation certificates on file? 5

Are sampling and sample handling procedures documented/is there a lab manual on file? Are specimen results reviewed and signed and dated by PI? Are specimen results that are out of range marked as clinically significant or not clinically significant? Are sample logs/records complete and on file? Is there on going storage of samples for future research? If yes; Are storage conditions monitored and recorded? Have all samples been analysed and destroyed as per protocol? 15. Pharmacy Are Pharmacy Staff GCP and CVs up to date and on file? Is the Delegation of Authority and signature log updated to reflect end of study? Are instructions in place with regards to handling trial medication and trial related materials? Dispensing procedure? Randomization/resupply/returns and destruction? IMP packaging samples? Is there a Pharmacy approved Prescription template on file? Records of drug dispensing on file and has the drug been correctly dispensed with all completed prescriptions on file? Have drug accountability records been completed? Are there adequate collection, recording and maintenance of temperature monitoring records for all locations storing IMPs? Have any drug excursions been recorded? Have any drug been quarantined? Are all required GMP, certificate of analysis and QP release documents on file? 6

16. Financial/Legal agreements Are all completed documents relating to contracts, finance, funding, indemnity and sponsorship on file? 17. Study Related Supplies Are all study related supplies documents completed and on file? Are all maintenance and calibration records completed and on file? 18. Annual/Final Reports Are annual progress and where applicable safety reports to the Ethics Committee on file? Are sponsor confirmations of annual report receipt on file? 19. Publication Are copies of all study analysis publications on file? 20. Correspondence Is all study related correspondence on file? 7

21. Source Data Verification Are all CRFs complete and all data queries resolved? Has all patient identifiable data been removed? Confirmation that Data Lock point has been achieved? Confirmation that a Statistical Analysis Plan (SAP) is in place? 22. Data Protection Are computer records and files containing identifiable data stored on a remote and secure server? Is the emergency recovery procedure for retrieving data available? Is access to electronic study records and files password protected? Are electronic data files for analysis anonymised? Confirmation that all personal data will be removed according to the timespan stated within the ethical application? Is there provision in place for suitable archiving? If yes are details logged with the sponsor? 23. Other Additional Comments/Overview 8

UoL Site close down Final Outstanding Issues Sign Off Sponsor Reference and Short Title: Date of Visit: Date of Report: Date Responses Due Back: No. Outstanding Issue Action required Action Taken Signature & Date 9

Close Down Report Completed By: Monitor : Telephone: e-mail: Signature: Date: Close Down Responses Approved by PI: PI Name: PI Signature: Date: Completed Close Down Report Approved by: Monitor : Signature: Date Close Down Report Closed: 10